Literature DB >> 28374270

Patterns of glaucoma progression in retinal nerve fiber and macular ganglion cell-inner plexiform layer in spectral-domain optical coherence tomography.

Hae Jin Kim1, Jin Wook Jeoung1, Byeong Wook Yoo2, Hee Chan Kim3, Ki Ho Park4.   

Abstract

PURPOSE: To evaluate the progressive changes of circumpapillary retinal nerve fiber layer (RNFL) and macular ganglion cell-inner plexiform layer (GCIPL) thicknesses measured by spectral-domain optical coherence tomography (Cirrus SD-OCT) in open-angle glaucoma.
METHODS: One hundred-fourteen eyes of open-angle glaucoma patients with localized RNFL defect who had 3 years' worth of annual RNFL photography and OCT measurements were enrolled in this retrospective study. The progression rates of serial RNFL and GCIPL thicknesses (µm), angular width (°) and area (mm2) of defect on RNFL and GCIPL deviation maps were determined by linear mixed-effect models.
RESULTS: Over a mean follow-up period of 3.16 years, 50 patients out of a total of 114 patients were classified as progressors based on the structural evaluation. The progressors showed significantly higher progression rates in average, 6 and 11 o'clock sector RNFL thicknesses, angular width and area of defect in RNFL deviation map, as well as inferotemporal and minimum GCIPL thicknesses than the non-progressors. The thicknesses of the 6 o'clock sector RNFL and minimum GCIPL exhibited the highest reduction rates among the RNFL and GCIPL parameters assessed, respectively.
CONCLUSIONS: When evaluating glaucoma progression by OCT, careful observation of the average, 6 and 11 o'clock sectors in RNFL and inferotemporal and minimum GCIPL thicknesses can be helpful. We can effectively assess early changes of glaucoma progression with GCIPL thickness as well as RNFL thickness.

Entities:  

Keywords:  Cirrus OCT; GCIPL progression; OCT glaucoma progression

Mesh:

Year:  2017        PMID: 28374270     DOI: 10.1007/s10384-017-0511-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  29 in total

Review 1.  Diagnosing glaucoma progression.

Authors:  Robert T Chang; Donald L Budenz
Journal:  Int Ophthalmol Clin       Date:  2008

2.  Long-Term Reproducibility of Macular Ganglion Cell Analysis in Clinically Stable Glaucoma Patients.

Authors:  Ko Eun Kim; Byeong Wook Yoo; Jin Wook Jeoung; Ki Ho Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

3.  Early Manifest Glaucoma Trial: design and baseline data.

Authors:  M C Leske; A Heijl; L Hyman; B Bengtsson
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

4.  Central corneal pachymetry and visual field progression in patients with open-angle glaucoma.

Authors:  Joshua W Kim; Philip P Chen
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

5.  Evaluation of retinal nerve fiber layer progression in glaucoma a prospective analysis with neuroretinal rim and visual field progression.

Authors:  Christopher Kai Shun Leung; Shu Liu; Robert N Weinreb; Gilda Lai; Cong Ye; Carol Yim Lui Cheung; Chi Pui Pang; Kwok Kay Tse; Dennis Shun Chiu Lam
Journal:  Ophthalmology       Date:  2011-04-29       Impact factor: 12.079

Review 6.  Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography.

Authors:  Dilraj S Grewal; Angelo P Tanna
Journal:  Curr Opin Ophthalmol       Date:  2013-03       Impact factor: 3.761

7.  Usefulness of macular thickness derived from spectral-domain optical coherence tomography in the detection of glaucoma progression.

Authors:  Kyoung Sub Lee; Jong Rak Lee; Jung Hwa Na; Michael S Kook
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-15       Impact factor: 4.799

8.  Macular and peripapillary retinal nerve fiber layer measurements by spectral domain optical coherence tomography in normal-tension glaucoma.

Authors:  Mincheol Seong; Kyung Rim Sung; Eun Hee Choi; Sung Yong Kang; Jung Woo Cho; Tae Woong Um; Yoon Jeon Kim; Seong Bae Park; Hun Eui Hong; Michael S Kook
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

9.  Errors in the diagnosis of visual field progression in normal-tension glaucoma.

Authors:  M Schulzer
Journal:  Ophthalmology       Date:  1994-09       Impact factor: 12.079

10.  Long-term reproducibility of cirrus HD optical coherence tomography deviation map in clinically stable glaucomatous eyes.

Authors:  Kyu Hwa Roh; Jin Wook Jeoung; Ki Ho Park; Beong Wook Yoo; Dong Myung Kim
Journal:  Ophthalmology       Date:  2013-02-09       Impact factor: 12.079

View more
  5 in total

1.  Segmental inner macular layer analysis with spectral-domain optical coherence tomography for early detection of normal tension glaucoma.

Authors:  Jih-Pin Lin; Pei-Wen Lin; Ing-Chou Lai; Jen-Chia Tsai
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

2.  Longitudinal Changes in Peripapillary Retinal Nerve Fiber Layer and Macular Ganglion Cell Inner Plexiform Layer in Progressive Myopia and Glaucoma Among Adolescents.

Authors:  Hui Xiao; Yimin Zhong; Yunlan Ling; Xiaoyu Xu; Xing Liu
Journal:  Front Med (Lausanne)       Date:  2022-03-22

3.  Comparison of retinal nerve fiber layer thickness and Bruch's membrane opening minimum rim width thinning rate in open-angle glaucoma.

Authors:  Donghee Park; Sung Pyo Park; Kyeong Ik Na
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

4.  Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression.

Authors:  Ha Min Kim; William E McKee; Katarzyna B Malendowicz; Abinaya A Thenappan; Emmanouil Tsamis; Melvi D Eguia; C Gustavo De Moraes; Robert Ritch; Donald C Hood
Journal:  J Glaucoma       Date:  2020-10       Impact factor: 2.290

5.  Topographic correlation and asymmetry analysis of ganglion cell layer thinning and the retinal nerve fiber layer with localized visual field defects.

Authors:  Alfonso Casado; Andrea Cerveró; Alicia López-de-Eguileta; Raúl Fernández; Soraya Fonseca; Juan Carlos González; Gema Pacheco; Elena Gándara; Miguel Á Gordo-Vega
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.